Abstract
Human and animal studies increasingly point toward a neural pathogenesis of the metabolic syndrome, involving hypothalamic and autonomic nervous system dysfunction. We hypothesized that increased very-low-density lipoprotein−triglyceride (VLDL–TG) secretion by the liver in a rat model for dyslipidemia, that is, the obese Zucker (fa/fa) rat, is due to relative hyperactivity of sympathetic, and/or hypoactivity of parasympathetic hepatic innervation. To test the involvement of the autonomic nervous system, we surgically denervated the sympathetic or parasympathetic hepatic nerve in obese Zucker rats. Our results show that cutting the sympathetic hepatic nerve lowers VLDL–TG secretion in obese rats, finally resulting in lower plasma TG concentrations after 6 weeks. In contrast, a parasympathetic denervation results in increased plasma total cholesterol concentrations. The effect of a sympathetic or parasympathetic denervation of the liver was independent of changes in humoral factors or changes in body weight or food intake. In conclusion, a sympathetic denervation improves the lipid profile in obese Zucker rats, whereas a parasympathetic denervation increases total cholesterol levels. We believe this is a novel treatment target, which should be further investigated.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D . Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study, 1987-1998. Circulation 2003; 107: 2190–2195.
Licht CM, Vreeburg SA, van Reedt Dortland AK, Giltay EJ, Hoogendijk WJ, DeRijk RH et al. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab 2010; 95: 2458–2466.
Straznicky NE, Grima MT, Sari CI, Eikelis N, Lambert EA, Nestel PJ et al. Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012; 61: 2506–2516.
Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M . Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376: 1903–1909.
Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393–1401.
Zucker LM . Hereditary obesity in the rat associated with hyperlipemia. Ann N Y Acad Sci 1965; 131: 447–458.
Fukuda N, Azain MJ, Ontko JA . Altered hepatic metabolism of free fatty acids underlying hypersecretion of very low density lipoproteins in the genetically obese Zucker rats. J Biol Chem 1982; 257: 14066–14072.
Morgan DA, Anderson EA, Mark AL . Renal sympathetic nerve activity is increased in obese Zucker rats. Hypertension 1995; 25: 834–838.
Huber DA, Schreihofer AM . Attenuated baroreflex control of sympathetic nerve activity in obese Zucker rats by central mechanisms. J Physiol 2010; 588: 1515–1525.
Tavares FL, Seelaender MC . Hepatic denervation impairs the assembly and secretion of VLDL-TAG. Cell Biochem Funct 2008; 26: 557–565.
Bruinstroop E, Pei L, Ackermans MT, Foppen E, Borgers AJ, Kwakkel J et al. Hypothalamic neuropeptide Y (NPY) controls hepatic VLDL-triglyceride secretion in rats via the sympathetic nervous system. Diabetes 2012; 61: 1043–1050.
Bruinstroop E, la Fleur SE, Ackermans MT, Foppen E, Wortel J, Kooijman S et al. The autonomic nervous system regulates postprandial hepatic lipid metabolism. Am J Physiol Endocrinol Metab. 2013; 304: E1089–E1096.
Kalsbeek A, La Fleur S, Van Heijningen C, Buijs RM . Suprachiasmatic GABAergic inputs to the paraventricular nucleus control plasma glucose concentrations in the rat via sympathetic innervation of the liver. J Neurosci 2004; 24: 7604–7613.
de Gasquet P, Pequignot E, Lemonnier D, Alexiu A . Adipose-tissue lipoprotein lipase activity and cellularity in the genetically obese Zucker rat (fa-fa). Biochem J 1973; 132: 633–635.
Cleary MP, Vasselli JR, Greenwood MR . Development of obesity in Zucker obese (fa/fa) rat in absence of hyperphagia. Am J Physiol 1980; 238: E284–E292.
Opsahl CA, Powley TL . Failure of vagotomy to reverse obesity in the genetically obese Zucker rat. Am J Physiol 1974; 226: 34–38.
Ferrari B, Arnold M, Carr RD, Langhans W, Pacini G, Bodvarsdottir TB et al. Subdiaphragmatic vagal deafferentation affects body weight gain and glucose metabolism in obese male Zucker (fa/fa) rats. Am J Physiol Regul Integr Comp Physiol 2005; 289: R1027–R1034.
Day JL, Metcalfe J, Simpson CN . Adrenergic mechanisms in control of plasma lipid concentrations. Br Med J (Clin Res Ed) 1982; 284: 1145–1148.
Izumida Y, Yahagi N, Takeuchi Y, Nishi M, Shikama A, Takarada et al. Glycogen shortage during fasting triggers liver-brain-adipose neurocircuitry tofacilitate fat utilization. Nat Commun 2013; 4: 2316.
Acknowledgements
This work is supported by NWO-ZonMw (TOP 91207036). We thank Emmely de Vries, Merel Rijnsburger and Rianne van der Spek, from the Department of Endocrinology and Metabolism, Academic Medical Center (AMC), University of Amsterdam; Marja Neeleman from the Department of Clinical Chemistry, Laboratory of Endocrinology, Academic Medical Center (AMC), University of Amsterdam, and Sander Houten and Simone Denis from the Laboratory Genetic Metabolic Diseases, Academic Medical Center (AMC), University of Amsterdam, for experimental assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on International Journal of Obesity website
Rights and permissions
About this article
Cite this article
Bruinstroop, E., Eliveld, J., Foppen, E. et al. Hepatic denervation and dyslipidemia in obese Zucker (fa/fa) rats. Int J Obes 39, 1655–1658 (2015). https://doi.org/10.1038/ijo.2015.122
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2015.122
This article is cited by
-
Multi-organ denervation: a novel approach to combat cardiometabolic disease
Hypertension Research (2023)
-
Morphometric analysis of the human common hepatic artery reveals a rich and accessible target for sympathetic liver denervation
Scientific Reports (2022)
-
Mechanisms underlying electro-mechanical dysfunction in the Zucker diabetic fatty rat heart: a model of obesity and type 2 diabetes
Heart Failure Reviews (2020)
-
Functional abolition of carotid body activity restores insulin action and glucose homeostasis in rats: key roles for visceral adipose tissue and the liver
Diabetologia (2017)